Concepedia

M. Green

MG

Statistics

Publications

2

Citations

101

H-Index

2

Active since

2018

Affiliations

Institut Gustave Roussy(Current)

M. Green is an author at Institut Gustave Roussy specializing in oncology, cancer pharmacology, and medicine.

Publications per year

2018–2018

2

Publications

2

Molecular correlates differentiate response to atezolizumab (atezo) + bevacizumab (bev) vs sunitinib (sun): Results from a phase III study (IMmotion151) in untreated metastatic renal cell carcinoma (mRCC)

Brian I. Rini, Mahrukh Huseni, Michael B. Atkins et al. · Annals of Oncology · 2018 · 72 citations

Medicine, Oncology, Pharmacology +15

Phase Ib study (COSMIC-021) of cabozantinib in combination with atezolizumab: Results of the dose escalation stage in patients (pts) with treatment-naïve advanced renal cell carcinoma (RCC)

N. Agarwal, Ulka N. Vaishampayan, M. Green et al. · Annals of Oncology · 2018 · 29 citations · Full text

Medicine, Oncology, Pharmacology +14

1–2 of 2